Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79381 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Macitentan (n-butyl analogue)
CAS :<p>Macitentan n-butyl analogue, an oral ETA/ETB receptor blocker, may treat IPF and PAH.</p>Formule :C20H21Br2N5O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :587.29BDZ-g
CAS :BDZ-g: potent, selective AMPA receptor antagonist; useful for researching neurological disorders.Formule :C21H21N5O2SDegré de pureté :99.97%Couleur et forme :SolidMasse moléculaire :407.49SDZ 220-040
CAS :<p>SDZ 220-040 是一种选择性哺乳动物 NMDA 受体拮抗剂，可诱导根系生长的部分无重力模式 。</p>Formule :C16H16Cl2NO6PDegré de pureté :98.13%Couleur et forme :SolidMasse moléculaire :420.18tert-Butyl Hydrogen Tetradecanedioate
CAS :Formule :C18H34O4Degré de pureté :>95.0%(GC)(T)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :314.47Veratramine
CAS :Formule :C27H39NO2Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :409.61(1E,4E)-1,5-Bis[3,5-bis(methoxymethoxy)phenyl]-1,4-pentadiene-3-one
CAS :Formule :C25H30O9Degré de pureté :>97.0%(HPLC)Couleur et forme :White to Yellow to Green powder to crystalMasse moléculaire :474.51D-2-Phenylglycine
CAS :Formule :C8H9NO2Degré de pureté :>99.0%(T)Couleur et forme :White to Almost white powder to crystalMasse moléculaire :151.174,4'-Diethynylbiphenyl
CAS :Formule :C16H10Degré de pureté :>98.0%(GC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :202.26Isobutyryl Chloride
CAS :Formule :C4H7ClODegré de pureté :>98.0%(GC)(T)Couleur et forme :Colorless to Light yellow clear liquidMasse moléculaire :106.554-Maleimidobutyric Acid
CAS :Formule :C8H9NO4Degré de pureté :>98.0%(GC)Couleur et forme :White to Almost white powder to crystalMasse moléculaire :183.16Nisoldipine Related Compound G (Diisobutyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C23H30N2O6Couleur et forme :Yellow PowderMasse moléculaire :430.21039Chlorothiophene carboxylic acid (5-chlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H3ClO2SCouleur et forme :Off-White Pale Yellow SolidMasse moléculaire :161.95423Eprosartan Related Compound C (2-(thiophen-2-ylmethyl)malonic acid) (DISCONTINUED)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C8H8O4SCouleur et forme :White PowderMasse moléculaire :200.01433Iscotrizinol Related Compound I (Bis(2-ethylhexyl) 4,4'-{[6-({4-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)carbamoyl]phenyl}amino)-1,3,5-triazine-2,4-diyl]bis(azanediyl)}dibenzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C55H71N7O7Couleur et forme :White PowderMasse moléculaire :941.5415Clavam-2-carboxylate Potassium
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormule :C6H6KNO4Couleur et forme :White FilmMasse moléculaire :194.99339Zalcitabine Related Compound A (2',3'-Didehydro-2',3'-dideoxycytidine) (DISCONTINUED)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C9H11N3O3Couleur et forme :PowderMasse moléculaire :209.08004Sulfamethazine Related Compound A (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate) (DISCONTINUED)
CAS :Sulfonamides, nesoiFormule :C7H10N4O2S·H2OCouleur et forme :White PowderMasse moléculaire :232.06301Loracarbef L-Isomer (DISCONTINUED)
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C16H16ClN3O4·3H2OCouleur et forme :PowderMasse moléculaire :403.82Modafinil Related Compound E (Bis(diphenylmethyl)disulfide) (DISCONTINUED)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C26H22S2Couleur et forme :White PowderMasse moléculaire :398.11629Modafinil Related Compound B (2-[(diphenylmethyl)sulfonyl]acetamide) (DISCONTINUED)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C15H15NO3SCouleur et forme :White PowderMasse moléculaire :289.07726Pamabrom Related Compound A (8-Chlorotheophylline) (DISCONTINUED)
CAS :Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormule :C7H7ClN4O2Couleur et forme :PowderMasse moléculaire :214.02575Modafinil Related Compound C (2-[(diphenylmethyl)sulfenyl]acetamide)
CAS :Other aromatic organo-sulfur compounds (excluding pestiFormule :C15H15NOSCouleur et forme :White PowderMasse moléculaire :257.08744Thioridazine Related Compound F (2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hydrochloride) (DISCONTINUED)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H24N2S2HClCouleur et forme :Pale Green Light Blue PowderMasse moléculaire :356.13809Ethylhexyl Triazone Related Compound C (Bis(2-ethylhexyl) 4,4'-[(6-{[4-(ethoxycarbonyl)phenyl]amino}-1,3,5-triazine-2,4-diyl)bis(azanediyl)]dibenzoate) (DISCONTINUED)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C42H54N6O6Couleur et forme :PowderMasse moléculaire :738.91Moexipril Related Compound C ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C35H46N2O11Couleur et forme :White PowderMasse moléculaire :670.310162-Ethylhexan-1-ol (DISCONTINUED)
CAS :2-ethylhexan-1-ol (octyl alcohol)Formule :C8H18OCouleur et forme :LiquidMasse moléculaire :130.22 g/molEthylhexyl Triazone Related Compound B (4-[(4,6-Bis[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C40H50N6O6Couleur et forme :PowderMasse moléculaire :710.86Eprosartan Related Compound D (4-(bromomethyl)benzoic acid) (DISCONTINUED)
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormule :C8H7BrO2Couleur et forme :White PowderMasse moléculaire :213.96294Nisoldipine Related Compound D (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C20H22N2O6Couleur et forme :Pale Yellow SolidMasse moléculaire :386.14779Probucol Related Compound C (4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol) (DISCONTINUED)
CAS :Other aromatic organo-sulfur compounds (excluding pestiFormule :C31H48O2S2Couleur et forme :PowderMasse moléculaire :516.86Amiodarone Related Compound B
CAS :Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormule :C23H25I2NO3Masse moléculaire :616.99239Lufenuron Related Compound G (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate)
CAS :Ureines and their derivatives; salts thereofFormule :C21H12Cl2F2N2O5Couleur et forme :PowderMasse moléculaire :480.00913Trospium Chloride Related Compound B ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H23NO3Couleur et forme :White Off-White SolidMasse moléculaire :337.16779Iscotrizinol Related Compound D (2-Ethylhexyl 4-[(4,6-bis{[4-(tert-butylcarbamoyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]benzoate) (DISCONTINUED)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C40H52N8O4Couleur et forme :White PowderMasse moléculaire :708.41115Rivaroxaban Open Ring ((R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20ClN3O4SCouleur et forme :Off-White SolidMasse moléculaire :409.0863Pravastatin Related Compound B (sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate)
CAS :Carboxylic acids w/ alcohol function but w/o other oxygFormule :C23H36O7Couleur et forme :PowderMasse moléculaire :424.2461Levalbuterol Related Compound B (α-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) (DISCONTINUED)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C13H21N02Couleur et forme :White PowderMasse moléculaire :205.17047Nefazodone Related Compound A (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) (PLANNED TO BE DISCONTINUED)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C13H18Cl2N2·HClCouleur et forme :White PowderMasse moléculaire :272.0847Ioxilan Related Compound A (5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic acid) (DISCONTINUED)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C10H9I3N2O4Couleur et forme :White PowderMasse moléculaire :601.76965Drometrizole Trisiloxane Related Compound E (2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) (DISCONTINUED)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C31H59N3O5Si6Couleur et forme :Pale Yellow LiquidMasse moléculaire :722.33Calcitonin Salmon Related Compound B (calcitonin salmon-glycine) (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS :Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormule :C147H242N44O50S2Couleur et forme :Colorless LiquidMasse moléculaire :3487.71879Amiodarone Related Compound F
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H17IO3Masse moléculaire :420.02224Iscotrizinol Related Compound B (4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) (DISCONTINUED)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C36H43N7O5Couleur et forme :White PowderMasse moléculaire :653.33257Sibutramine Related Compound C (N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine hydrochloride)
Aromatic monoamines not elsewhere specified or includedFormule :C17H26ClN·HClCouleur et forme :White Crystalline PowderMasse moléculaire :316.3Deacetylnorgestimate ((E)- and (Z)-17-deacetyl norgestimate mixture) (DISCONTINUED)
CAS :Estrogens and progestinsFormule :C21H29NO2Couleur et forme :White PowderMasse moléculaire :327.21983Bemotrizinol Impurity Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :Light Yellow PowderProguanil Related Compound C (1,5-bis(4-chlorophenyl)biguanide hydrochloride)
CAS :Aromatic imines and their derivatives, salts thereofFormule :C14H13Cl2N5·HClCouleur et forme :White Crystalline PowderMasse moléculaire :321.0548Isocyclosporin A
CAS :Lactams, nesoiFormule :C62H111N11O12Couleur et forme :White Off-White PowderMasse moléculaire :1201.84137Modafinil Related Compound D (Bis(diphenylmethyl)ether) (DISCONTINUED)
CAS :Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C26H22OCouleur et forme :White PowderMasse moléculaire :350.16707Moexipril Related Compound B ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H-pyrazino[1,2-b]isoquinolin-2(6H,11H,11aH)-yl}-4-phenylbutanoate)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C27H32N2O6Couleur et forme :Off-White SolidMasse moléculaire :480.22604Ethylhexyl Triazone Related Compound A (2-ethylhexyl 4-aminobenzoate) (DISCONTINUED)
CAS :Aromatic amino-acids and their esters, other than thoseFormule :C15H23NO2Couleur et forme :PlatesMasse moléculaire :249.17288Drometrizole Trisiloxane Related Compound B (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol) (DISCONTINUED)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C17H17N3OCouleur et forme :Pale Yellow PowderMasse moléculaire :279.13716Iloperidone Related Compound A ([4'-(3-Chloropropoxy)-3'-methoxy]acetophenone) (DISCONTINUED)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatives: chlordecone (iso)Formule :C12H15ClO3Couleur et forme :PowderMasse moléculaire :242.07097Probucol Related Compound B (4,4'-dithio-bis(2,6-di-tert-butylphenol)) (DISCONTINUED)
Other aromatic organo-sulfur compounds (excluding pestiFormule :C28H42O2S2Couleur et forme :Pale Yellow Crystalline SolidMasse moléculaire :474.77Cinacalcet Related Compound B
Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C32H31F6NCouleur et forme :Brown LiquidMasse moléculaire :543.6Amitraz Related Compound B (N'-(2,4-Dimethylphenyl)-N-methylformimidamide) (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS :Aromatic imines and their derivatives, salts thereofFormule :C10H14N2Couleur et forme :PowderMasse moléculaire :162.1157Eprosartan Related Compound B (3-(thiophen-2-yl)propanoic acid) (DISCONTINUED)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C7H8O2SCouleur et forme :White Beige SolidMasse moléculaire :156.0245Amiodarone Related Compound G
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C26H31I2NO4Masse moléculaire :675.03425Vortioxetine Related Compound I
CAS :<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formule :C18H22N2SMasse moléculaire :298.15037Iscotrizinol Related Compound C (2-Ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-chloro-1,3,5-triazin-2-yl)amino]benzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C29H37ClN6O3Couleur et forme :White Off-White PowderMasse moléculaire :552.26157Ethopabate Related Compound A (Methyl-4-acetamido-2-hydroxybenzoate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C10H11NO4Couleur et forme :Tan PowderMasse moléculaire :209.06881Eprosartan Related Compound E (4-(hydroxymethyl)benzoic acid) (DISCONTINUED)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormule :C8H8O3Couleur et forme :Beige White PowderMasse moléculaire :152.04734Dalfampridine Related Compound A (4-Aminopyridine 1-oxide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C5H6N2OCouleur et forme :White SolidMasse moléculaire :110.04801Open Ring N-Methyl Clopidogrel Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-(methyl(2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride) (DISCONTINUED)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H18ClNO2S·HClCouleur et forme :White Off-White SolidMasse moléculaire :359.05136Nisoldipine Related Compound E (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C20H22N2O5Couleur et forme :Green SolidMasse moléculaire :370.15287Cyclosporin H
CAS :Lactams, nesoiFormule :C62H111N11O12Couleur et forme :White Off-White SolidMasse moléculaire :1201.84137Sulfamethazine Related Compound B (Mixture containing about 49% of 4-Amino-2-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide and about 48% of 4-Amino-3-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide) (DISCONTINUED)
Sulfonamides, nesoiCouleur et forme :White Off-White SolidIoversol Related Compound A (5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) (DISCONTINUED)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C14H18I3N3O6Couleur et forme :Off-White Tan Crystalline PowderMasse moléculaire :704.83298Oxaliplatin Related Compound B ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') dinitratoplatinum(II))
CAS :Inorganic or organic compounds of precious metals, whetFormule :C6H14N4O6PtCouleur et forme :White Pale Yellow Crystalline PowderMasse moléculaire :433.05613Melphalan Enantiomer
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C13H18Cl2N2O2·HClMasse moléculaire :340.05121Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid)
CAS :Compounds (excluding drugs and pesticides) containing aFormule :C25H30N2O7Couleur et forme :PowderMasse moléculaire :470.2053Cidofovir Related Compound A (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C10H18N3O6PCouleur et forme :White Off-White PowderMasse moléculaire :307.09332Dihydrodaunorubicin Hydrochloride ((8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride) (DISCONTINUED)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C27H31NO10·HClCouleur et forme :PowderMasse moléculaire :565.17147Cinacalcet Related Compound E
Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C10H11F3OCouleur et forme :Colorless Clear Light Yellow Light Brown LiquidMasse moléculaire :204.0762Eprosartan Related Compound A ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid hydrochloride) (DISCONTINUED)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H18N2O2S·HClCouleur et forme :Off-White PowderMasse moléculaire :290.1089Drometrizole Trisiloxane Related Compound C (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) (DISCONTINUED)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C24H37N3O3Si3Couleur et forme :Colorless LiquidMasse moléculaire :499.83Iscotrizinol Related Compound F (Bis(2-ethylhexyl) 4,4'-({6-[(4-carbamoylphenyl)amino]-1,3,5-triazine-2,4-diyl}bis(azanediyl))dibenzoate) (DISCONTINUED)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C40H51N7O5Couleur et forme :White Off-White PowderMasse moléculaire :709.39517Amitraz Related Compound A (N-(2,4-Dimethylphenyl)formamide) (DISCONTINUED)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C9H11NOCouleur et forme :PowderMasse moléculaire :149.08406Orlistat Related Compound D (N-formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester) (DISCONTINUED)
CAS :Lactones, nesoiFormule :C29H53NO5Couleur et forme :LiquidMasse moléculaire :495.39237Gadoversetamide Related Compound A (DISCONTINUED)
Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, excluding cerium compounds, nesoiFormule :C17H27N4O10GdCouleur et forme :White PowderMasse moléculaire :604.67Epoprostenol Related Compound B (Sodium 5-(diphenylphosphinoyl)pentanoate) (DISCONTINUED)
Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C17H18NaO3PCouleur et forme :White PowderMasse moléculaire :324.08913Drometrizole Trisiloxane Related Compound D (2-(2H-Benzotriazol-2-yl)-6-isobutyl-p-cresol) (DISCONTINUED)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C17H19N3OCouleur et forme :Pale Yellow PowderMasse moléculaire :281.35Drometrizole Trisiloxane Related Compound A (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) (DISCONTINUED)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C17H17N3OCouleur et forme :Yellow PowderMasse moléculaire :279.13716Fentanyl Related Compound B (4-Anilinopiperidine)
CAS :Produit contrôléCompounds containing an unfused pyridine ring in the structure, nesoiFormule :C11H16N2Couleur et forme :White PowderMasse moléculaire :176.13135Nisoldipine Related Compound C (Isobutyl (Z)-2-(2-nitrobenzylidene)-3-oxobutanoate) (DISCONTINUED)
Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormule :C15H17NO5Couleur et forme :Pale Yellow SolidMasse moléculaire :291.11067Dicloxacillin Related Compound D (3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H7Cl2NO3Couleur et forme :PowderMasse moléculaire :270.9803Paroxetine Related Compound E Mixture (1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix) (DISCONTINUED)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiCouleur et forme :White Off-White Crystalline PowderIscotrizinol Related Compound G (2-Ethylhexyl 4-{4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzamido}benzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C51H64N8O6Couleur et forme :PowderMasse moléculaire :884.49488Amiodarone Related Compound C
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H30INO3Masse moléculaire :519.127042-BUTENOIC ACID, 2-METHYL-, (5S,6S,7S,13AS)-5,6,7,8-TETRAHYDRO-6-HYDROXY-1,2,3,13-TETRAMETHOXY-6,7-DIMETHYLBENZO[3,4]CYCLOOCTA[1,2-F][1,3]BENZODIOXOL-5-YL ESTER, (2Z)-
CAS :Formule :C28H34O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :514.5642Dammarane-3,12-diol, 20,25-epoxy-, (3b,12b,20R)-
CAS :Formule :C30H52O3Couleur et forme :SolidMasse moléculaire :460.7321Platinum, diammine[1,1-cyclobutanedi(carboxylato-kO)(2-)]-, (SP-4-2)-
CAS :Formule :C6H10N2O4PtDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :369.23263,6-Dichloro-1,2,4,5-tetrazine
CAS :Formule :C2Cl2N4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :150.9542(2R,3R)-3,3',4',5,7-Pentahydroxyflavanone
CAS :Formule :C15H12O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :304.2516(11β,16α)-9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
CAS :Formule :C24H31FO6Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :434.4977Ergosta-5,7,22-trien-3-ol, (3b,22E)-
CAS :Formule :C28H44ODegré de pureté :95%Couleur et forme :SolidMasse moléculaire :396.6484Ref: IN-DA00IA6A
Produit arrêté2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-onehydrochloride
CAS :Formule :C13H19Cl2NODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :276.20215-(Ethylthio)-1H-tetrazole
CAS :Formule :C3H6N4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :130.1715
![(1E,4E)-1,5-Bis[3,5-bis(methoxymethoxy)phenyl]-1,4-pentadiene-3-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3B%2Fthumb-webp%2FB4823.webp&w=3840&q=75)
![Modafinil Related Compound C (2-[(diphenylmethyl)sulfenyl]acetamide)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1445368.webp&w=3840&q=75)
![Thioridazine Related Compound F (2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1663063.webp&w=3840&q=75)
![Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrah…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1445608.webp&w=3840&q=75)
![Platinum, diammine[1,1-cyclobutanedi(carboxylato-kO)(2-)]-, (SP-4-2)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I84B.webp&w=3840&q=75)
![(11β,16α)-9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0039HQ.webp&w=3840&q=75)
